Below are the financial statements of Cytokinetics, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of USD | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenues | — | — | — |
| License and milestone revenues | 15a | 3.5a | 1a |
| Collaboration revenues | 3.47a | 4.03a | 6.59a |
| Realization of revenue participation right purchase agreement | 0a | 0a | 87a |
| Total revenues | 18.47a | 7.53a | 94.59a |
| Operating expenses | — | — | — |
| Research and development | -339.41a | -330.12a | -240.81a |
| General and administrative | -215.31a | -173.61a | -177.98a |
| Total operating expenses | -554.72a | -503.74a | -418.79a |
| Operating loss | -536.25a | -496.21a | -324.2a |
| Interest expense | -37.7a | -28.31a | -19.41a |
| Loss on extinguishment of debt | 0a | 0a | -24.94a |
| Non-cash interest expense on liabilities related to revenue participation right purchase agreements | -48.81a | -29.36a | -31.74a |
| Interest and other income, net | 51.53a | 27.63a | 11.34a |
| Change in fair value of derivative liabilities | 1.3a | 0a | 0a |
| Change in fair value of liabilities related to RPI transactions | -19.6a | 0a | 0a |
| Net loss | -589.53a | -526.24a | -388.96a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Cytokinetics’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.